Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine
Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura, Momoko Kurihara, Ryousuke Koike, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
doi: https://doi.org/10.1101/2021.08.06.21261590
Yushi Nomura
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University
Michiru Sawahata
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
3Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University
Yosikazu Nakamura
4Department of Public Health, Jichi Medical University
Momoko Kurihara
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
Ryousuke Koike
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University
Otohiro Katsube
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
Koichi Hagiwara
3Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University
Seiji Niho
2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University
Norihiro Masuda
5Department of Surgery, National Hospital Organization Utsunomiya National Hospital
Takaaki Tanaka
6Department of Orthopaedic Surgery, National Hospital Organization Utsunomiya National Hospital
Kumiya Sugiyama
1Department of Respiratory Medicine and Clinical Immunology, National Hospital Organization Utsunomiya National Hospital
7Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University Saitama Medical Center
Data Availability
All data referred to in the manuscript are available.
Posted August 07, 2021.
Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine
Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura, Momoko Kurihara, Ryousuke Koike, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
medRxiv 2021.08.06.21261590; doi: https://doi.org/10.1101/2021.08.06.21261590
Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine
Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura, Momoko Kurihara, Ryousuke Koike, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
medRxiv 2021.08.06.21261590; doi: https://doi.org/10.1101/2021.08.06.21261590
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4286)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2767)
- Health Policy (1025)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4063)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6667)
- Radiology and Imaging (1456)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)